Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

Novo opens doors on new US headquarters

$225m redevelopment for New Jersey life science offices

Novartis day

Xolair gets asthma green light from NICE

Final guidance recommends Novartis drug for severe persistent asthma 

- PMLiVE

BMS wins wider NICE Orencia arthritis approval

But only after cutting the drug's price

- PMLiVE

AstraZeneca supports NHS medication passport app

Backs NIHR-NHS initiative under joint working agreement

Roche - Basel

Roche to shut Applied Science unit

170 jobs in the firing line as pharma company reorganises diagnostic presence

- PMLiVE

Former Pfizer exec Stephen Williams joins Venaxis board

Is current chief medical officer of SomaLogic

- PMLiVE

NICE set to hand Bayer wider recommendation for Xarelto

Backs drug’s use to treat pulmonary embolism and prevent DVT

- PMLiVE

Charting a sea change in medical education

The medical education landscape has changed significantly over recent years. There are many reasons for this sea change, but two stand out...

- PMLiVE

FDA approves Alcon eye drug Simbrinza

Fixed-combination licensed to treat glaucoma patients in the US

- PMLiVE

Team Gold

Putting a best practice sharing model in place

- PMLiVE

Online social gaming campaign takes aim at cancer

EPAAC's I'm a Fan of Life initiative focuses on cancer prevention

- PMLiVE

EC gives green light to new 6-in-1 childhood vaccine from Sanofi, MSD

Hexyon/Hexacima protects against diphtheria, DTP, hepatitis B, polio, meningitis and Haemophilus influenzae type B

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links